Niagen Bioscience Inc (NASDAQ:NAGE)’s traded shares stood at 0.73 million during the last session, with the company’s beta value hitting 2.15. At the close of trading, the stock’s price was $7.75, to imply an increase of 1.44% or $0.11 in intraday trading. The NAGE share’s 52-week high remains $9.18, putting it -18.45% down since that peak but still an impressive 70.19% since price per share fell to its 52-week low of $2.31. The company has a valuation of $602.56M, with an average of 0.79 million shares in intraday trading volume over the past 10 days and average of 801.24K shares over the past 3 months.
Niagen Bioscience Inc (NASDAQ:NAGE) trade information
After registering a 1.44% upside in the last session, Niagen Bioscience Inc (NAGE) has traded red over the past five days. The 5-day price performance for the stock is -1.15%, and 36.08% over 30 days. With these gigs, the year-to-date price performance is 46.09%. Short interest in Niagen Bioscience Inc (NASDAQ:NAGE) saw shorts transact 2.11 million shares and set a 5.91 days time to cover.
NAGE Dividends
Niagen Bioscience Inc has its next earnings report out on 2025-Mar-03. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Niagen Bioscience Inc (NASDAQ:NAGE)’s Major holders
Niagen Bioscience Inc insiders hold 34.79% of total outstanding shares, with institutional holders owning 30.00% of the shares at 46.01% float percentage. In total, 30.00% institutions holds shares in the company.
We also have Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF as the top two Mutual Funds with the largest holdings of the Niagen Bioscience Inc (NAGE) shares. Going by data provided on Dec 31, 2024 , Vanguard Total Stock Market Index Fund holds roughly 2.12 shares. This is just over 2.73% of the total shares, with a market valuation of $16.46 million. Data from the same date shows that the other fund manager holds a little less at 1.38, or 1.77% of the shares, all valued at about 10.69 million.
